| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/19/2006 | US20060014188 System to detect inducible translocation |
| 01/19/2006 | US20060014187 Association of single nucleotide polymorphisms in PPARgamma with osteoporosis |
| 01/19/2006 | US20060014186 Methods for genotype screening of a strain disposed on an adsorbent carrier |
| 01/19/2006 | US20060014185 Integrated nucleic acid analysis |
| 01/19/2006 | US20060014184 Contacting a compound with a polypeptide having a specific amino acid sequence and measuring a compound-polypeptide property related to extra-cellular matrix (ECM) degradation, e.g., activation of a biological pathway producing a biochemical marker indicative of ECM degradation such as MMP1 |
| 01/19/2006 | US20060014183 Extendable probes |
| 01/19/2006 | US20060014182 Using hybrid RNA/DNA primer to replicate/propagate preferential messengegr RNA polynucleotides; gene expression analysis and drug discovery |
| 01/19/2006 | US20060014181 Detection of DNA mismatches and oxidative lesions |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060014179 Inferring function from shotgun sequencing data |
| 01/19/2006 | US20060014178 Use of Mrf-2 for screening and therapies |
| 01/19/2006 | US20060014177 A sample storage substrate comprising an elastomeric substrate made of open cell foam, closed cell foam, or a combination thereof and a biological sample absorbed by the elastomeric substrate; resists degradation |
| 01/19/2006 | US20060014176 Reactor for chemical synthesis |
| 01/19/2006 | US20060014175 Functionalized fluorescent nanocrystal detection system |
| 01/19/2006 | US20060014174 Method for the detection and identification of circulating micrometastatic cancer cells |
| 01/19/2006 | US20060014173 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/19/2006 | US20060014172 Aptamer-nanoparticle conjugates and method of use for target analyte detection |
| 01/19/2006 | US20060014171 detecting colon cancer cells by detecting the quantity of SENP1 and/or telomerase; inhibitor of SENP1 protease activity |
| 01/19/2006 | US20060014170 Detection without amplification and interference; measuring efficacy; packaged array can be used in robotic assembly for automated analysis |
| 01/19/2006 | US20060014169 Methods for obtaining directionally truncated polypeptides |
| 01/19/2006 | US20060014168 Method of diagnosis of inclusion body myopathy-paget bone disease-frontotemporal dementia syndrome |
| 01/19/2006 | US20060014167 Amplification of trace amounts of nucleic acids |
| 01/19/2006 | US20060014166 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
| 01/19/2006 | US20060014165 Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association |
| 01/19/2006 | US20060014164 Computer software to assist in identifying SNPS with microarrays |
| 01/19/2006 | US20060014163 forming complexes between dsDNA and novel DNA-binding polymers comprising N-terminal thiophene-containing moieties which exhibit selectivity for T-A base pairs |
| 01/19/2006 | US20060014162 As a target for drug development against Chagas' disease |
| 01/19/2006 | US20060014161 Combination comprising biochip and optical detection device |
| 01/19/2006 | US20060014160 Determining whether or not mammary gland sodium/iodide symporter (mgNIS) is expressed in breast tissue of the subject, whereinexpression of mgNIS in the breast tissue is detected using an antibody, specific for mgNIS, expression of mgNIS in the breast tissue of is indicative of breast cancer presence |
| 01/19/2006 | US20060014159 Methods of determining precise HERG interactions and designing compounds based on said interactions |
| 01/19/2006 | US20060014158 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 01/19/2006 | US20060014157 Sensitivity test to predict efficacy of anti-cancer therapies |
| 01/19/2006 | US20060014156 Nucleic acid detecting or quantifying processes |
| 01/19/2006 | US20060014155 Methods for the production of sensor arrays using electrically addressable electrodes |
| 01/19/2006 | US20060014154 contacting degraded DNA fragments with a reaction mixture, purifying repaired concatamerized DNA from plurality of substantially purified enzymes and amplifying purified repaired concatamerized DNA using a whole genome amplification method |
| 01/19/2006 | US20060014153 Polypeptides as target for drugs to detect central nervous system disorders; cancer; metabolism; cardiovascular disorders |
| 01/19/2006 | US20060014152 Methods and reaction mixture reagent for increasing the specificity and fidelity of polymerase reactions |
| 01/19/2006 | US20060014151 Optical dna sensor, dna reading apparatus, identification method of dna and manufacturing method of optical dna sensor |
| 01/19/2006 | US20060014150 Development of therapeutics for the treatment of endotoxin-meidated diseases |
| 01/19/2006 | US20060014149 Methods for rolling circle amplification and signal trapping of libraries |
| 01/19/2006 | US20060014148 Igg fc/hiv-gp120/c3d fusion protien |
| 01/19/2006 | US20060014147 Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) |
| 01/19/2006 | US20060014146 Method of creating a library of bacterial clones with varying levels of gene expression |
| 01/19/2006 | US20060014145 Methods and articles for high throughput analysis of biomolecular interactions |
| 01/19/2006 | US20060014144 Pseudonucleotide comprising an intercalator |
| 01/19/2006 | US20060014143 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 01/19/2006 | US20060014142 Compositions and methods for detection of hepatitis A virus nucleic acid |
| 01/19/2006 | US20060014141 Method of detecting and quantifying cytomegalovirus |
| 01/19/2006 | US20060014140 Molecular methods and compositions for detecting and quantifying respiratory viruses |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060014138 detecting the presence or absence of a humoral response to a tumor antigen selected from Eukaryotic Translation Initiation Factor 4Gamma 1 (eIF4G 1), Ribosomal Protein L22 (RPL22), Ribosomal Protein L 13A (RPL13A), and protein XP-373908; prostate cancer |
| 01/19/2006 | US20060014137 System for cell-based screening |
| 01/19/2006 | US20060014136 Method of screening for protection from microbial infection |
| 01/19/2006 | US20060014135 Assay for distinguishing live and dead cells |
| 01/19/2006 | US20060013831 adjuvant peptide and heterologous an antigen; human immunodeficiency virus (HIV)-related peptides; antigen is cholera toxin; fusion protein |
| 01/19/2006 | US20060013829 Nucleic acid segments; coding zones; genetic engineered cells |
| 01/19/2006 | US20060013827 Method of diagnosing FIV |
| 01/19/2006 | US20060013826 Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions |
| 01/19/2006 | US20060013822 Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines |
| 01/19/2006 | US20060013817 identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which said genetic products that are expressed in association with a tumor are expressed in an aberrant manner. |
| 01/19/2006 | US20060013813 Proteins and nucleic acids encoding same |
| 01/19/2006 | US20060013805 Transgenic circulating endothelial cells |
| 01/19/2006 | US20060013804 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 01/19/2006 | US20060013735 Ultraphobic surface having a multitude of reversibly producible hydrophilic and/or oleophilic areas |
| 01/19/2006 | US20060013732 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 01/19/2006 | US20060013725 Disposable cartridge for characterizing particles suspended in a liquid |
| 01/19/2006 | US20060011911 Detection of molecular probes fixed to an active zone of a sensor |
| 01/19/2006 | US20060011549 Solid compositions for selective adsorption from complex mixtures |
| 01/19/2006 | US20060011478 Integration of biochemical protocols in a continuous flow microfluidic device |
| 01/19/2006 | DE10306089B4 Verfahren und Testbesteck zur Bestimmung von neuroimmunologischen gesundheitlichen Störungen Method and test kit for the determination of neuroimmunological health disorders |
| 01/19/2006 | DE10231659B4 Zusammensetzung zum Binden von Nukleinsäure an eine Festphase Composition for binding nucleic acid to a solid phase |
| 01/19/2006 | DE102005008908A1 Novel polypeptide having biological activity of NAD- or NADP-dependent alcohol dehydrogenase, useful for producing compounds such as enantiomerically pure alcohols |
| 01/19/2006 | DE102004032872A1 Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Thymidylat-Kinasen A method for identifying fungicidally active compounds based on thymidylate kinases |
| 01/19/2006 | DE10043470B4 Verfahren zur Identifizierung von zellspezifischen Proteinen A method for identifying cell-specific protein |
| 01/19/2006 | CA2838428A1 Compositions and methods for detection of hepatitis a virus nucleic acid |
| 01/19/2006 | CA2573532A1 Compositions and methods for detection of hepatitis a virus nucleic acid |
| 01/19/2006 | CA2573090A1 Differences in intestinal gene expression profiles |
| 01/19/2006 | CA2572681A1 Cancer treatment resistance and agents modulating such resistance |
| 01/19/2006 | CA2572675A1 Methods for predicting therapeutic response to agents acting on the growth hormone receptor |
| 01/19/2006 | CA2572472A1 Methods and compositions to detect nucleic acids in a biological sample |
| 01/19/2006 | CA2572313A1 Non-invasive glucose measurement |
| 01/19/2006 | CA2571921A1 Microfluidic device for performing a plurality of reactions and uses thereof |
| 01/19/2006 | CA2571154A1 Jm-27 asa a marker of benign prostatic hyperplasia |
| 01/19/2006 | CA2570921A1 Methods related to a single nucleotide polymorphism of the g protein coupled receptor, gpr40 |
| 01/19/2006 | CA2570351A1 Sensor-dispensing instrument and method of using the same |
| 01/19/2006 | CA2570350A1 Detecting incomplete fill of biosensors |
| 01/19/2006 | CA2569190A1 Method for the detection of fusarium graminearum |
| 01/19/2006 | CA2566806A1 Methods and devices for nucleic acid sequence determination |
| 01/19/2006 | CA2566804A1 Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia |
| 01/19/2006 | CA2475174A1 Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells |
| 01/18/2006 | EP1617219A1 Element having bioactive substance fixed thereto |
| 01/18/2006 | EP1617216A1 Novel method of screening |
| 01/18/2006 | EP1616967A2 Primers for isothermal amplification and genotyping of Hepatitis C virus |
| 01/18/2006 | EP1616966A2 Enhancement of alkaline phosphatase with SDS in chemiluminescent substrates and enzyme inhibition assays |
| 01/18/2006 | EP1616965A1 Methods and assays for detecting guanylate cyclase activity |
| 01/18/2006 | EP1616953A1 Method of detecting beta 3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor |
| 01/18/2006 | EP1616952A1 Method of detecting pancryatic islet amyloid protein mutant gene and nucleic acid probe and kit therefor |
| 01/18/2006 | EP1616951A1 Method of isolating nucleic acid and, for nucleic acid isolation, kit and apparatus |
| 01/18/2006 | EP1616947A1 METHOD OF SYNTHESIZING cDNA |
| 01/18/2006 | EP1616942A2 Patched genes and their use |